| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/31/2006 | WO2006090072A1 Ppar activator derivatives, preparation method thereof and use of same in therapeutics |
| 08/31/2006 | WO2006090067A1 Solid pharmaceutical composition comprising telithromycin |
| 08/31/2006 | WO2006090052A1 Novel 3-aryl-1,2-benzisoxazole derivatives, compositions containing same and use thereof |
| 08/31/2006 | WO2006090047A1 Use of a pyrazole derivative for preparing medicines useful for preventing or treating renal diseases |
| 08/31/2006 | WO2006090029A1 Gemcitabine derivatives nanoparticles |
| 08/31/2006 | WO2006089973A2 Dosage form containing oxycodone and naloxone |
| 08/31/2006 | WO2006089942A1 Protease inhibitor precursor synthesis |
| 08/31/2006 | WO2006089909A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments |
| 08/31/2006 | WO2006089881A1 Use of phenanthrene derivatives as anti-inflammatory agents, synthesis method and intermediate products |
| 08/31/2006 | WO2006089874A1 Benzo[2,3]azepino[4,5-b]indol-6-ones |
| 08/31/2006 | WO2006089872A1 Glucopyranosyl-substituted ( (hetero)arylethynyl-benzyd-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors |
| 08/31/2006 | WO2006089871A2 Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias |
| 08/31/2006 | WO2006089861A2 Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neurotransmission |
| 08/31/2006 | WO2006089859A1 Novel drugs for treating respiratory diseases |
| 08/31/2006 | WO2006089815A1 Novel pyrrolodihydroisoquinolines as pde10 inhibitors |
| 08/31/2006 | WO2006089804A1 Aqueous topical gel of high stability based on metronidazole and method of preparation |
| 08/31/2006 | WO2006089803A1 Method and composition to inhibit infections with helicobacter pylori by intake of procyanidins from type b and c |
| 08/31/2006 | WO2006089798A1 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors |
| 08/31/2006 | WO2006089787A1 Amorphous lercanidipine hydrochloride |
| 08/31/2006 | WO2006089781A1 Pharmaceutical combination of bcr-abl and raf inhibitors |
| 08/31/2006 | WO2006089746A1 Purification process |
| 08/31/2006 | WO2006089708A1 Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride |
| 08/31/2006 | WO2006089707A1 Phosphate salts of 6-dimethylaminomethyl-l-(3-methoxyphenyl) -1,3-dihydroxycyclohexane compounds |
| 08/31/2006 | WO2006089700A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists |
| 08/31/2006 | WO2006089689A1 2-quinolone compounds as inhibitors of phosphodiesterases |
| 08/31/2006 | WO2006089664A2 Heterocyclylamide-substituted imidazoles |
| 08/31/2006 | WO2006089658A2 Nk1 antagonists |
| 08/31/2006 | WO2006089656A2 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent |
| 08/31/2006 | WO2006089561A1 Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix. |
| 08/31/2006 | WO2006089546A1 Tablets comprising a high load of strontium |
| 08/31/2006 | WO2006089494A1 Osmotic device containing amantadine and an osmotic salt |
| 08/31/2006 | WO2006089478A1 The use of isoscutellarin for the manufacture of medicine |
| 08/31/2006 | WO2006089406A1 Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents |
| 08/31/2006 | WO2006089397A1 Methods for treating arthritis using triheterocyclic compounds |
| 08/31/2006 | WO2006089348A1 Anti-microbial agent |
| 08/31/2006 | WO2006089317A1 Pharmaceutical dosage form effective at microcirculatory level containing at least one flavonoid |
| 08/31/2006 | WO2006078824A3 Eggshell membrane separation method |
| 08/31/2006 | WO2006078287A9 Pde4b inhibitors and uses therefor |
| 08/31/2006 | WO2006074940A3 Macrocyclic compounds and compositions useful as bace inhibitors |
| 08/31/2006 | WO2006074914A3 Human rna helicase and therapeutic uses thereof |
| 08/31/2006 | WO2006074388A3 TRICYCLIC δ-OPIOID MODULATORS |
| 08/31/2006 | WO2006074223A3 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof |
| 08/31/2006 | WO2006073572A3 Treatment of conditions caused by calcium abnormalities |
| 08/31/2006 | WO2006072599A3 Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
| 08/31/2006 | WO2006072393A3 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 08/31/2006 | WO2006070288A3 Aerosol generator |
| 08/31/2006 | WO2006069242A3 Fused pyrazole derivatives and uses thereof in methods of treatment of metabolic-related?disorders |
| 08/31/2006 | WO2006066957A3 Sulfonamido-macrocycles as tie2 inhibitors |
| 08/31/2006 | WO2006066924A3 Azole derivatives with antimuscarinic activity |
| 08/31/2006 | WO2006066896A3 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 08/31/2006 | WO2006065711A3 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists |
| 08/31/2006 | WO2006065555A3 Use of alpha-adrenergic blockers for the treatment of dysmenorrhea |
| 08/31/2006 | WO2006062984A3 Inhibitors of protein kinases |
| 08/31/2006 | WO2006061155A3 Stabilisation of glucocorticoid esters with acids |
| 08/31/2006 | WO2006060614A9 Methods for preparing pimecrolimus |
| 08/31/2006 | WO2006059194A3 Pharmaceutical sustained-release composition containing clozapine |
| 08/31/2006 | WO2006057769A3 Method of delivering nasal spray |
| 08/31/2006 | WO2006056696A3 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
| 08/31/2006 | WO2006056399A3 Combinations of jak inhibitors and at least one of bcr-abl, flt-3, fak or raf kinase inhibitors |
| 08/31/2006 | WO2006050965A8 Pyrimidine compounds as histamine modulators |
| 08/31/2006 | WO2006048747A8 Topical pharmaceutical compositions containing an antiacne compound and antibiotic compound |
| 08/31/2006 | WO2006044933B1 Compositions and methods for disruption of brca2-rad51 interaction |
| 08/31/2006 | WO2006040481A3 Method for diagnosing and treating crohn's disease |
| 08/31/2006 | WO2006035418A3 Microcapsules comprising a methylxanthine and a corticosteroid |
| 08/31/2006 | WO2006035417A3 Dihydropyrimidine microcapsule - formulations |
| 08/31/2006 | WO2006035244A3 Ecteinascidin compounds as anti -inflammatory agents |
| 08/31/2006 | WO2006035068A3 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 08/31/2006 | WO2006033709A3 Novel nucleoside derivatives |
| 08/31/2006 | WO2006031610A3 Bicyclic anilide spirolactam cgrp receptor antagonists |
| 08/31/2006 | WO2006027786A8 Use of liposomal glucocorticoids for treating inflammatory states |
| 08/31/2006 | WO2006027345A3 Novel 3-thia-10-aza-phenanthrene derivatives |
| 08/31/2006 | WO2006026368A3 Development of fluorogenic substrates for monoamine oxidases (mao-a and mao-b) |
| 08/31/2006 | WO2006023852A3 Modulators of muscarinic receptors |
| 08/31/2006 | WO2006020003A3 Ophthalmic compositions for treating ocular hypertension |
| 08/31/2006 | WO2006017524A3 Preventing pathological increases in the rate of nerve cell suicide in immature nervous systems |
| 08/31/2006 | WO2006013193A3 Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors |
| 08/31/2006 | WO2006010969A8 New heterocyclic carboxylic acid amide derivatives |
| 08/31/2006 | WO2006010077A3 Prodrugs of lonidamine and lonidamine analogs |
| 08/31/2006 | WO2006009602A3 Multiple ppi dosage form |
| 08/31/2006 | WO2006003013B1 NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1 |
| 08/31/2006 | WO2006000228A3 Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 08/31/2006 | WO2005115380A3 Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins |
| 08/31/2006 | WO2005111038A3 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 08/31/2006 | WO2005110391A3 Compounds for treating human papillomavirus |
| 08/31/2006 | WO2005107792A3 Compositions and methods for treatment of protein misfolding diseases |
| 08/31/2006 | WO2005092441A3 Extended cycle multiphasic oral contraceptive method |
| 08/31/2006 | WO2005077968A3 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 08/31/2006 | WO2005056014A8 Methods for suppressing an immune response or a treating a proliferative disorder |
| 08/31/2006 | WO2005051318A3 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 08/31/2006 | WO2005044273A8 Controlled release delivery system for nasal applications |
| 08/31/2006 | WO2005041894A3 Compositions and methods for treating, preventing, reversing and inhibiting pain |
| 08/31/2006 | WO2005039503A3 Prenylation inhibitors reduce host cell permissiveness to viral replication |
| 08/31/2006 | WO2005035507A3 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| 08/31/2006 | WO2005030118A3 Targeted release of nitric oxide in the cns circulation for modulating the bbb and treating disorders |
| 08/31/2006 | WO2005015159A3 Methods for modulating a drug-related effect or behavior |
| 08/31/2006 | WO2004087053A3 Dipeptidyl peptidase inhibitors |
| 08/31/2006 | US20060194972 Process for the production of imidazopyridin-8-ones |
| 08/31/2006 | US20060194971 Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neruotransmission |
| 08/31/2006 | US20060194970 Process for producing imide compound |
| 08/31/2006 | US20060194968 Cyclic benizimidazoles |